Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone for Mania in Children and Adolescents With Bipolar Disorder
NCT00181922Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ziprasidone in bipolar disorder (BD) and mania, sponsored by Massachusetts General Hospital. Primary endpoints: Reduction in symptoms at 10 months, Clinical Global Improvement scale at 10 months and 1 more. Started Mar 2002; status: completed.
02
Drugs
ziprasidone
03
Conditions
bipolar disorder (BD)mania
Beyond the preview
Go deeper on NCT00181922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181922.